Cost of the Cervical Cancer Screening Program at the Mexican Social Security Institute

Abstract

Objective. To estimate the annual cost of the National Cervical Cancer Screening Program (CCSP) of the Mexican Institute of Social Security (IMSS). Materials and methods. This cost analysis examined regional coverage rates reported by IMSS. We estimated the number of cytology, colposcopy, biopsy and pathology evaluations, as well as the diagnostic test and treatment costs for cervical intraepithelial neoplasia grade II and III (CIN 2/3) and cervical cancer. Diagnostic test costs were estimated using a micro-costing technique. Sensitivity analyses were performed. Results. The cost to perform 2.7 million cytology tests was nearly 38 million dollars, which represents 26.1% of the total program cost (145.4 million). False negatives account for nearly 43% of the program costs. Conclusion. The low sensitivity of the cytology test generates high rates of false negatives, which results in high institutional costs from the treatment of undetected cervical cancer cases.

Prevalence of Human Papillomavirus in Women from the State of Michoacan, Mexico, Showed High Frequency of Unusual Virus Genotypes

“…After colposcopy study, 51% of samples were reclassified as LSIL. Granados-García et al 17 found false negative PAPs in 42.6% of samples, while we found 26.66% of false negatives (Table 2). Altogether, these results suggest that colposcopy is a better assay than cytology to predict HPV infections causing lesions in the histopathology assay.…”

Assessment of the Validity and Reproducibility of the Pap Smear in Mexico: Necessity of a Paradigm Shift

“…With this background, in the context of countries such as Mexico, the operative problems of the population's utilization of the Pap test are magnified including non-optimal practices for cytology specimen collection, deficient fixation and staining and, most particularly, lacking competencies in cytology diagnosis as evidenced by this study (38). Therefore, it is necessary to change the paradigm of using the Pap test, favoring its high specificity, and to find the evidence of its greater efficiency when used as a triage strategy in HPV-positive women.…”

Cervical Cancer Screening in Patients with Total Hysterectomy in a Diagnostic Center at Mexico City

“…[ 2 3 ] The use of these different screening methods depends on the organization of the local health system and the resources available. [ 2 3 ] Because the material resources to identify cervical preinvasive lesions can consume large amounts of the institutional budget,[ 4 5 ] it is essential to make screening more effective and efficient.…”